Gladstone investigator Andrew Yang receives 2026 Sobrato Prize in Neuroscience
Grant and Award Announcement
In honor of Alzheimer's Awareness Month, we’re exploring the science and stories surrounding Alzheimer’s disease.
Updates every hour. Last Updated: 20-Jun-2026 23:15 ET (21-Jun-2026 03:15 GMT/UTC)
This year’s recipient of the Sobrato Prize in Neuroscience is Andrew Yang, PhD, whose research has reshaped scientific understanding of the blood-brain barrier and its role in brain health and disease. Yang is an investigator at the Gladstone Institute of Neurological Disease and an assistant professor of neurology and anatomy at the University of California, San Francisco. Launched in 2024, the Sobrato Prize in Neuroscience seeks to bridge the gap between discovery and the clinic, accelerating life-changing brain science with high potential for patient impact. It is awarded to scientists at Gladstone Institutes whose research has a particularly high potential to lead to new therapies for major brain diseases.
Dr. Owen Carmichael has been awarded the James W. and Neil Ann Parks Professorship for Dementia Research, Prevention and Treatment. James and Neil Ann Parks are longtime supporters of Pennington Biomedical. They intend for this professorship to be part of their legacy in understanding, preventing and treating dementia, Alzheimer’s disease, Lewy body dementia and other diseases of the brain, and believe that through this work, new diagnostics and treatments will be developed until a cure is found. Endowed professorships are among the highest academic honors bestowed upon a faculty member and recognize excellence in research, scholarship and leadership.
Columbia researchers identify how harmful tau filaments may first form, opening potential path toward developing new treatments for Alzheimer’s disease, which affects millions of people worldwide.